GUERBET

Welcome to the Brand page for “GUERBET”, which is offered here for In the statement, column 1, line 8 after treatment, cough drops, should be inserted. in the statement, column 1, line 9 after lozenges, cough syrup, should be inserted. in the statement, column 1, line 10 after disinfectant, diuretic, should be inserted.;house mark for a full line of pharmaceuticals, barium, allergy capsules, contrast media products for radio diagnostic treatment, * cough drops, * cough expectorant, cough lozenges, * cough syrup, * all purpose disinfectant, * diuretic, * eye drops, in vivo diagnostic products, narcotic analgesic, nasal decongestant capsules, tablets, tampons, and throat lozenges;.

Its status is currently believed to be active. Its class is unavailable. “GUERBET” is believed to be currently owned by “GUERBET S.A.”


Owner:
GUERBET S.A.
Owner Details
Description:
IN THE STATEMENT, COLUMN 1, LINE 8 AFTER TREATMENT, COUGH DROPS, SHOULD BE INSERTED. IN THE STATEMENT, COLUMN 1, LINE 9 AFTER LOZENGES, COUGH SYRUP, SHOULD BE INSERTED. IN THE STATEMENT, COLUMN 1, LINE 10 AFTER DISINFECTANT, DIURETIC, SHOULD BE INSERTED.;HOUSE MARK FOR A FULL LINE OF PHARMACEUTICALS, BARIUM, ALLERGY CAPSULES, CONTRAST MEDIA PRODUCTS FOR RADIO DIAGNOSTIC TREATMENT, * COUGH DROPS, * COUGH EXPECTORANT, COUGH LOZENGES, * COUGH SYRUP, * ALL PURPOSE DISINFECTANT, * DIURETIC, * EYE DROPS, IN VIVO DIAGNOSTIC PRODUCTS, NARCOTIC ANALGESIC, NASAL DECONGESTANT CAPSULES, TABLETS, TAMPONS, AND THROAT LOZENGES;
Categories: IN STATEMENT